Adam A Nishimura1, Brian H Shirts2, Michael O Dorschner2,3,4, Laura M Amendola5, Joe W Smith6, Gail P Jarvik3,5, Peter Tarczy-Hornoch1,7,8. 1. Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington, USA. 2. Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA. 3. Department of Genome Sciences, University of Washington, Seattle, Washington, USA. 4. Department of Pathology, University of Washington, Seattle, Washington, USA. 5. Department of Medicine, Division of Medical Genetics, University of Washington, Seattle, Washington, USA. 6. Department of Pharmacy, University of Washington, Seattle, Washington, USA. 7. Department of Pediatrics, University of Washington, Seattle, Washington, USA. 8. Department of Computer Science and Engineering, University of Washington, Seattle, Washington, USA.
Abstract
PURPOSE: Electronic health records (EHRs) and their associated decision support tools are potentially important means of disseminating a patient's pharmacogenomic profile to his or her health-care providers. We sought to create a proof-of-concept decision support alert system generated from pharmacogenomic incidental findings from exome sequencing. METHODS: A pipeline for alerts from exome sequencing tests was created for patients in the New EXome Technology in (NEXT) Medicine study at the University of Washington. Decision support rules using discrete, machine-readable incidental finding results were programmed into a commercial EHR rules engine. An evaluation plan to monitor the alerts in real medical interactions was established. RESULTS: Alerts were created for 48 actionable pharmacogenomic variants in 11 genes and were launched on 24 September 2014 for University of Washington inpatient care. Of the 94 participants enrolled in the NEXT Medicine study, 49 had one or more pharmacogenomic variants identified for return. CONCLUSION: Reflections on the process reveal that while incidental findings can be used to generate decision support alerts, substantial resources are required to ensure that each alert is consistent with rapidly evolving pharmacogenomic literature and is customized to fit in the clinical workflow unique to each incidental finding.
PURPOSE: Electronic health records (EHRs) and their associated decision support tools are potentially important means of disseminating a patient's pharmacogenomic profile to his or her health-care providers. We sought to create a proof-of-concept decision support alert system generated from pharmacogenomic incidental findings from exome sequencing. METHODS: A pipeline for alerts from exome sequencing tests was created for patients in the New EXome Technology in (NEXT) Medicine study at the University of Washington. Decision support rules using discrete, machine-readable incidental finding results were programmed into a commercial EHR rules engine. An evaluation plan to monitor the alerts in real medical interactions was established. RESULTS: Alerts were created for 48 actionable pharmacogenomic variants in 11 genes and were launched on 24 September 2014 for University of Washington inpatient care. Of the 94 participants enrolled in the NEXT Medicine study, 49 had one or more pharmacogenomic variants identified for return. CONCLUSION: Reflections on the process reveal that while incidental findings can be used to generate decision support alerts, substantial resources are required to ensure that each alert is consistent with rapidly evolving pharmacogenomic literature and is customized to fit in the clinical workflow unique to each incidental finding.
Authors: Jan Horsky; Gordon D Schiff; Douglas Johnston; Lauren Mercincavage; Douglas Bell; Blackford Middleton Journal: J Biomed Inform Date: 2012-09-17 Impact factor: 6.317
Authors: Michael O Dorschner; Laura M Amendola; Brian H Shirts; Lesli Kiedrowski; Joseph Salama; Adam S Gordon; Stephanie M Fullerton; Peter Tarczy-Hornoch; Peter H Byers; Gail P Jarvik Journal: Am J Med Genet C Semin Med Genet Date: 2014-03-10 Impact factor: 3.908
Authors: Alan R Shuldiner; Kathleen Palmer; Ruth E Pakyz; Tameka D Alestock; Kristin A Maloney; Courtney O'Neill; Shaun Bhatty; Jamie Schub; Casey Lynnette Overby; Richard B Horenstein; Toni I Pollin; Mark D Kelemen; Amber L Beitelshees; Shawn W Robinson; Miriam G Blitzer; Patrick F McArdle; Lawrence Brown; Linda Jo Bone Jeng; Richard Y Zhao; Nicholas Ambulos; Mark R Vesely Journal: Am J Med Genet C Semin Med Genet Date: 2014-03-10 Impact factor: 3.908
Authors: James M Hoffman; Cyrine E Haidar; Mark R Wilkinson; Kristine R Crews; Donald K Baker; Nancy M Kornegay; Wenjian Yang; Ching-Hon Pui; Ulrike M Reiss; Aditya H Gaur; Scott C Howard; William E Evans; Ulrich Broeckel; Mary V Relling Journal: Am J Med Genet C Semin Med Genet Date: 2014-03-11 Impact factor: 3.908
Authors: Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg Journal: N Engl J Med Date: 2013-11-19 Impact factor: 91.245
Authors: Marilyn D Paterno; Saverio M Maviglia; Paul N Gorman; Diane L Seger; Eileen Yoshida; Andrew C Seger; David W Bates; Tejal K Gandhi Journal: J Am Med Inform Assoc Date: 2008-10-24 Impact factor: 4.497
Authors: Munir Pirmohamed; Girvan Burnside; Niclas Eriksson; Andrea L Jorgensen; Cheng Hock Toh; Toby Nicholson; Patrick Kesteven; Christina Christersson; Bengt Wahlström; Christina Stafberg; J Eunice Zhang; Julian B Leathart; Hugo Kohnke; Anke H Maitland-van der Zee; Paula R Williamson; Ann K Daly; Peter Avery; Farhad Kamali; Mia Wadelius Journal: N Engl J Med Date: 2013-11-19 Impact factor: 91.245
Authors: Wylie Burke; Armand H Matheny Antommaria; Robin Bennett; Jeffrey Botkin; Ellen Wright Clayton; Gail E Henderson; Ingrid A Holm; Gail P Jarvik; Muin J Khoury; Bartha Maria Knoppers; Nancy A Press; Lainie Friedman Ross; Mark A Rothstein; Howard Saal; Wendy R Uhlmann; Benjamin Wilfond; Susan M Wolf; Ron Zimmern Journal: Genet Med Date: 2013-08-01 Impact factor: 8.822
Authors: Jonathan S Berg; Laura M Amendola; Christine Eng; Eliezer Van Allen; Stacy W Gray; Nikhil Wagle; Heidi L Rehm; Elizabeth T DeChene; Matthew C Dulik; Fuki M Hisama; Wylie Burke; Nancy B Spinner; Levi Garraway; Robert C Green; Sharon Plon; James P Evans; Gail P Jarvik Journal: Genet Med Date: 2013-10-24 Impact factor: 8.822
Authors: Cyrine E Haidar; Kristine R Crews; James M Hoffman; Mary V Relling; Kelly E Caudle Journal: Annu Rev Genomics Hum Genet Date: 2022-05-10 Impact factor: 9.340
Authors: Adam A Nishimura; Brian H Shirts; Joseph Salama; Joe W Smith; Beth Devine; Peter Tarczy-Hornoch Journal: Int J Med Inform Date: 2015-11-11 Impact factor: 4.046
Authors: Greyson P Twist; Andrea Gaedigk; Neil A Miller; Emily G Farrow; Laurel K Willig; Darrell L Dinwiddie; Josh E Petrikin; Sarah E Soden; Suzanne Herd; Margaret Gibson; Julie A Cakici; Amanda K Riffel; J Steven Leeder; Deendayal Dinakarpandian; Stephen F Kingsmore Journal: NPJ Genom Med Date: 2016-01-13 Impact factor: 8.617
Authors: Marc Hinderer; Martin Boeker; Sebastian A Wagner; Martin Lablans; Stephanie Newe; Jan L Hülsemann; Michael Neumaier; Harald Binder; Harald Renz; Till Acker; Hans-Ulrich Prokosch; Martin Sedlmayr Journal: BMC Med Inform Decis Mak Date: 2017-06-06 Impact factor: 2.796
Authors: Elizabeth M J Lee; Karen Xu; Emma Mosbrook; Amanda Links; Jessica Guzman; David R Adams; Elise Flynn; Elise Valkanas; Camillo Toro; Cynthia J Tifft; Cornelius F Boerkoel; William A Gahl; Murat Sincan Journal: Genet Med Date: 2016-06-02 Impact factor: 8.822